Forms
Access key forms for authorizations, claims, pharmacy and more.
Administrative
- Abortion/Miscarriage Certification (PDF)
- Adding New Provider to Existing Contract (PDF)
- Appointment of Representative (PDF)
- Delivery Notification (PDF)
- EPSDT Well Child Exam Fillable (PDF)
- ER Medical Review Request (PDF)
- Hysterectomy Consent (PDF)
- Notice of Pregnancy Form (PDF)
- PCP Change Request Form (PDF)
- PCP Request for Transfer of Member (PDF)
- Prenatal Reward Visits Log (PDF)
- Requesting Interpreter Services Form (PDF)
- Sterilization Consent (PDF)
- Update Provider Deomographics/Other (PDF)
- WW Baseline Form (PDF)
- WW Outcome Form (PDF)
Behavioral Health
- ACT Services Request Form (PDF)
- Detox and Substance Abuse Rehab Service Request (PDF)
- Discharge Summary (PDF)
- Electroconvulsive Therapy Services Request (PDF)
- ACT Services Request Form (PDF)
- Detox and Substance Abuse Rehab Service Request (PDF)
- Discharge Summary (PDF)
- Electroconvulsive Therapy Services Request (PDF)
- Inpatient, Sub-Acute and CSU Service Request (PDF)
- PHP and IOP Service Request (PDF)
- Psychological and Neuropsychological Testing Service Request (PDF)
- Residential Treatment Service Request (PDF)
- Routine Outpatient Services Request (PDF)
- Targeted Case Management Service Request (PDF)
Phamacy
- Medical Drug Authorization Request (PDF)
- Medication Appeal Request Form (To Appeal Initial Drug Denial with Date of Service before 7/1) (PDF)
- Synagis Order (PDF)
- Universal Prior Authorization Form (PDF)
- CP.PHAR.230: AbobotulinumtoxinA (Dysport) (PDF)
- CP.PHAR.231: IncobotulinumtoxinA (Xeomin) (PDF)
- CP.PHAR.232: OnabotulinumtoxinA (Botox) (PDF)
- CP.PHAR.233: RimabotulinumtoxinB (Myobloc) (PDF)
- CP.PHAR.288: Eteplirsen (Exondys 51) (PDF)
- CP.PHAR.335: Ocrelizumab (Ocrevus) (PDF)
- CP.PHAR.343: Edaravone (Radicava) (PDF)
- CP.PHAR.354: Testosterone (Testopel, Jatenzo) (PDF)
- CP.PHAR.361: Tisagenlecleucel (Kymriah) (PDF)
- CP.PHAR.362: Axicabtagene Ciloleucel (Yescarta) (PDF)
- CP.PHAR.372: Voretigene Neparvovec-rzyl (Luxturna) (PDF)
- CP.PHAR.378: Ibalizumab-uiyk (Trogarzo) (PDF)
- CP.PHAR.416: Caplacizumab-yhdp (Cablivi) (PDF)
- CP.PHAR.468: Aducanumab-avwa (Aduhelm) (PDF)
- Spinal Muscular Atrophy (Evrysdi, Zolgensma) Update
Quality
- Behavioral Health Measure Changes Tip Sheet (PDF)
- Behavioral Health Follow-Up Measures Tip Sheet (PDF)
- Provider CAHPS® Resource Guide (PDF)
- Provider CAHPS® Tip Sheet (PDF)
- LOINC® Codes and HEDIS (PDF)
- Culturally Linguistic and Appropriate Services: CLAS Flyer (PDF)
- LOINC® Codes and HEDIS (PDF)
- Partnership for Quality (P4Q) Program Announcement (PDF)
- Tobacco Cessation Performance Improvement Project Flyer (PDF)
Quality Rating System (QRS) Measurement Year 2024
HEDIS Measurement Year 2024 Toolkit